Samit Hirawat
Director · Pacira BioSciences, Inc.
- 2024
- Jun 13, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Samit Hirawat files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David V. Elkins - $1.85M in BMY purchases and sales in the last 12 months
- Shawn Cross - $895K in PCRX purchases and sales in the last 12 months
- Kristen Williams - $498K in PCRX purchases and sales in the last 12 months
- Lauren Riker - $445K in PCRX purchases and sales in the last 12 months
- Cristian Massacesi - $403K in BMY purchases and sales in the last 12 months
- Jonathan Slonin - $240K in PCRX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Samit Hirawat?
Samit Hirawat is a corporate insider, tracked as Director of Pacira BioSciences, Inc. (PCRX). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Samit Hirawat last file a Form 4?
The most recent primary Form 4 on record is dated 13 June 2026, one of 3 filings going back to 2024.
Has Samit Hirawat been buying or selling stock?
Recorded transactions: 1 open-market purchase ($100K) and 0 open-market sales across all tracked filings.
